首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1542405

全球静脉解决方案市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Intravenous Solutions Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 222 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球静脉注射解决方案市场需求预计将从 2023 年的 179.9 亿美元达到近 354.9 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 7.84%。

静脉 (IV) 溶液是直接注射到患者静脉的无菌液体，用于输送药物、营养物质或液体以达到治疗目的。对于无法口服液体或需要立即吸收药物的患者来说，这些解决方案在医疗环境中至关重要。静脉注射液通常含有水、电解质（钠、钾和氯化物）的均衡组合，有时还含有葡萄糖或药物等其他物质。它们在维持水合和电解质平衡以及支持接受手术、疾病復健或管理慢性病的患者的重要功能方面发挥着不可或缺的作用。静脉注射液有多种类型和成分可供选择，可根据特定的医疗需求和治疗要求进行定制，确保精确的输送和治疗效果。

市场动态

慢性病、手术和医疗紧急情况的日益普及需要可靠的静脉解决方案来补充液体、药物输送和营养支持。医疗技术的进步，例如改进的输液帮浦和导管设计，提高了静脉注射的安全性和效率，有助于改善病患的治疗效果并减少住院时间。人口老化和复杂疾病发病率上升等人口趋势推动了市场成长。门诊护理和家庭医疗保健环境的扩大进一步推动了对静脉注射解决方案的需求，患者需要方便、便携式的输液选择来进行持续治疗管理。

静脉注射治疗的技术创新，包括智慧静脉注射帮浦和整合电子病历，提高了治疗精确度和病患监测，促进了医疗机构的采用。此外，旨在提高病患安全和品质标准的监管措施为合规静脉注射解决方案製造商创造了扩大市场份额和创新新产品的机会。製药公司、医疗器材製造商和医疗保健提供者之间的策略合作促进了产品开发和分销，增强了全球市场竞争力和可扩展性。然而，医疗保健系统中对产品审批和定价动态的严格监管要求阻碍了市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球静脉解决方案市场的每个细分市场进行了包容性评估。静脉注射解决方案产业的成长和趋势为本研究提供了整体方法。

市场区隔

静脉解决方案市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按类型

全肠外营养
週边肠外营养

按成分分类

碳水化合物
维生素和矿物质
单剂量胺基酸
肠外脂质乳剂
其他成分

按年龄段

儿科
成人
老年科

按申请

营养支持
输血
液体和电解质平衡
其他应用

按最终用户

医院和诊所
门诊手术中心
居家照护环境

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲静脉解决方案市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。静脉注射解决方案市场的主要参与者包括Ajinomoto Co Inc.、Amanta Healthcare、Axa Parenterals Ltd、B.Braun Melsungen AG、Baxter International Inc.、Fresenius Kabi USA LLC、Grifols SA、ICU Medical Inc、JW Life Science、Otsuka Pharmaceutical有限公司、辉瑞公司。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按类型分類的市场吸引力分析
- 按构成进行的市场吸引力分析
- 按年龄组别分類的市场吸引力分析
- 市场吸引力分析：依应用分类
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球静脉注射解决方案市场分析：按类型

按类型概述
按类型分析历史和预测数据
全肠外营养
週边肠外营养

第 6 章：全球静脉注射解决方案市场分析：依构成

按成分概述
按成分分析历史和预测数据
碳水化合物
维生素和矿物质
单剂量胺基酸
肠外脂质乳剂
其他成分

第 7 章：全球静脉注射解决方案市场分析：按年龄组

按年龄组别概述
按年龄组别进行的历史和预测资料分析
儿科
成人
老年科

第 8 章：全球静脉注射解决方案市场分析：按应用分类

概述：按应用
历史与预测资料分析：按应用分类
营养支持
输血
液体和电解质平衡
其他应用

第 9 章：全球静脉注射解决方案市场分析：按最终用户分类

最终用户概述
最终用户的历史和预测数据分析
医院和诊所
门诊手术中心
居家照护环境

第 10 章：全球静脉注射解决方案市场分析：按地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 11 章：静脉注射液公司的竞争格局

静脉注射解决方案市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 12 章：公司简介

顶级公司市占率分析
市场集中度
Ajinomoto Co Inc.

公司概况
公司收入
产品
最新动态

Amanta Healthcare

公司概况
公司收入
产品
最新动态

Axa Parenterals Ltd

公司概况
公司收入
产品
最新动态

B.Braun Melsungen AG

公司概况
公司收入
产品
最新动态

Baxter International Inc.

公司概况
公司收入
产品
最新动态

Fresenius Kabi USA LLC

公司概况
公司收入
产品
最新动态

Grifols SA

公司概况
公司收入
产品
最新动态

ICU Medical Inc

公司概况
公司收入
产品
最新动态

JW Life Science

公司概况
公司收入
产品
最新动态

Otsuka Pharmaceutical Co. Ltd

公司概况
公司收入
产品
最新动态

Pfizer Inc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11219483

The global demand for Intravenous Solutions Market is presumed to reach the market size of nearly USD 35.49 Billion by 2032 from USD 17.99 Billion in 2023 with a CAGR of 7.84% under the study period 2024-2032.

Intravenous (IV) solutions are sterile fluids administered directly into a patient's veins to deliver medications, nutrients, or fluids for therapeutic purposes. These solutions are essential in medical settings for patients who cannot consume liquids orally or require immediate absorption of medications. Intravenous solutions typically contain a balanced combination of water, electrolytes (sodium, potassium, and chloride), and sometimes additional substances like glucose or medications. They play an integral role in maintaining hydration & electrolyte balance and supporting vital functions in patients undergoing surgery, recovering from illnesses, or managing chronic conditions. IV solutions are available in various types and compositions, which are customized to meet specific medical needs and treatment requirements, ensuring precise delivery and therapeutic efficacy.

MARKET DYNAMICS

The increasing prevalence of chronic diseases, surgeries, and medical emergencies necessitates reliable intravenous solutions for fluid replacement, medication delivery, and nutritional support. Advances in medical technology, such as improved infusion pumps and catheter designs, enhance the safety and efficiency of IV administration, contributing to better patient outcomes and reduced hospital stays. Demographic trends such as aging populations and the rising incidence of complex diseases drive market growth. The demand for intravenous solutions is further bolstered by the expansion of outpatient care and home healthcare settings, where patients require convenient and portable infusion options for continuous therapy management.

Technological innovations in IV therapy, including smart IV pumps and integrated electronic medical records, improve treatment precision and patient monitoring, promoting adoption across healthcare facilities. Moreover, regulatory initiatives to enhance patient safety and quality standards create opportunities for compliant intravenous solutions manufacturers to expand their market presence and innovate new products. Strategic collaborations among pharmaceutical companies, medical device manufacturers, and healthcare providers facilitate product development and distribution, enhancing market competitiveness and scalability globally. However, stringent regulatory requirements for product approval and pricing dynamics in healthcare systems hampers market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Intravenous Solutions. The growth and trends of Intravenous Solutions industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Intravenous Solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Total Parenteral Nutrition
Peripheral Parenteral Nutrition

By Composition

Carbohydrates
Vitamins & Minerals
Single-Dose Amino Acids
Parenteral Lipid Emulsion
Other Compositions

By Age Group

Pediatric
Adult
Geriatric

By Application

Nutritional Support
Blood Transfusion
Fluid & Electrolyte Balance
Other Applications

By End-User

Hospitals And Clinics
Ambulatory Surgery Centers
Home Care Setting

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Intravenous Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Intravenous Solutions market include Ajinomoto Co Inc., Amanta Healthcare, Axa Parenterals Ltd, B.Braun Melsungen AG, Baxter International Inc., Fresenius Kabi USA LLC, Grifols S.A., ICU Medical Inc, JW Life Science, Otsuka Pharmaceutical Co. Ltd, Pfizer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INTRAVENOUS SOLUTIONS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Composition
- 3.7.3 Market Attractiveness Analysis By Age Group
- 3.7.4 Market Attractiveness Analysis By Application
- 3.7.5 Market Attractiveness Analysis By End-User
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Total Parenteral Nutrition Historic and Forecast Sales By Regions
5.4. Peripheral Parenteral Nutrition Historic and Forecast Sales By Regions

6. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY COMPOSITION

6.1. Overview By Composition
6.2. Historical and Forecast Data Analysis By Composition
6.3. Carbohydrates Historic and Forecast Sales By Regions
6.4. Vitamins & Minerals Historic and Forecast Sales By Regions
6.5. Single-Dose Amino Acids Historic and Forecast Sales By Regions
6.6. Parenteral Lipid Emulsion Historic and Forecast Sales By Regions
6.7. Other Compositions Historic and Forecast Sales By Regions

7. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY AGE GROUP

7.1. Overview By Age Group
7.2. Historical and Forecast Data Analysis By Age Group
7.3. Pediatric Historic and Forecast Sales By Regions
7.4. Adult Historic and Forecast Sales By Regions
7.5. Geriatric Historic and Forecast Sales By Regions

8. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY APPLICATION

8.1. Overview By Application
8.2. Historical and Forecast Data Analysis By Application
8.3. Nutritional Support Historic and Forecast Sales By Regions
8.4. Blood Transfusion Historic and Forecast Sales By Regions
8.5. Fluid & Electrolyte Balance Historic and Forecast Sales By Regions
8.6. Other Applications Historic and Forecast Sales By Regions

9. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY END-USER

9.1. Overview By End-User
9.2. Historical and Forecast Data Analysis By End-User
9.3. Hospitals And Clinics Historic and Forecast Sales By Regions
9.4. Ambulatory Surgery Centers Historic and Forecast Sales By Regions
9.5. Home Care Setting Historic and Forecast Sales By Regions

10. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE INTRAVENOUS SOLUTIONS COMPANIES

11.1. Intravenous Solutions Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF INTRAVENOUS SOLUTIONS INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Ajinomoto Co Inc.
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Amanta Healthcare
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Axa Parenterals Ltd
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. B.Braun Melsungen AG
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. Baxter International Inc.
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Fresenius Kabi USA LLC
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Grifols S.A.
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. ICU Medical Inc
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. JW Life Science
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Otsuka Pharmaceutical Co. Ltd
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments
12.13. Pfizer Inc
- 12.13.1 Company Overview
- 12.13.2 Company Revenue
- 12.13.3 Products
- 12.13.4 Recent Developments